The Relationship Between Abdominal Body Composition and Metabolic Syndrome After a Weight Reduction Program in Adult Men with Obesity

References

• Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. doi:10.1016/S0140-6736(05)67483-1
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781. doi:10.1016/S0140-6736(14)60460-8
   PubMed Web of Science ®Google Scholar
• Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab. 2015;66(Suppl 2):7–12. doi:10.1159/000375143
   PubMed Web of Science ®Google Scholar
• Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105(8):626–635. doi:10.1016/S0929-6646(09)60161-3
   PubMed Web of Science ®Google Scholar
• Chang HC, Yang HC, Chang HY, et al. Morbid obesity in Taiwan: prevalence, trends, associated social demographics, and lifestyle factors. PLoS One. 2017;12(2):e0169577. doi:10.1371/journal.pone.0169577
   PubMed Web of Science ®Google Scholar
• Sandeep S, Gokulakrishnan K, Velmurugan K, Deepa M, Mohan V. Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians. Indian J Med Res. 2010;131:629–635.
   PubMed Web of Science ®Google Scholar
• Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311(7017):1401–1405. doi:10.1136/bmj.311.7017.1401
   PubMed Web of Science ®Google Scholar
• Després JP. From syndrome X to cardiometabolic risk: clinical and public health implications. Proc Nutr Soc. 2019;1–7. doi:10.1017/S0029665119001010
   PubMedGoogle Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/CIRCULATIONAHA.106.675355
   PubMed Web of Science ®Google Scholar
• Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: association for weight management and obesity prevention; NAASO, the obesity society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring). 2007;15(5):1061–1067. doi:10.1038/oby.2007.632
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–2716. doi:10.1001/jama.288.21.2709
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689. doi:10.2337/diacare.24.4.683
   PubMed Web of Science ®Google Scholar
• Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162. doi:10.1155/2014/943162
   PubMedGoogle Scholar
• Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–769. doi:10.7326/0003-4819-159-11-201312030-00008
   PubMed Web of Science ®Google Scholar
• Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008;57(5):1269–1275. doi:10.2337/db07-1378
   PubMed Web of Science ®Google Scholar
• Cereda E, Malavazos AE, Caccialanza R, Rondanelli M, Fatati G, Barichella M. Weight cycling is associated with body weight excess and abdominal fat accumulation: a cross-sectional study. Clin Nutr. 2011;30(6):718–723. doi:10.1016/j.clnu.2011.06.009
   PubMed Web of Science ®Google Scholar
• Seligman BG, Polanczyk CA, Santos AS, et al. Intensive practical lifestyle intervention improves endothelial function in metabolic syndrome independent of weight loss: a randomized controlled trial. Metabolism. 2011;60(12):1736–1740. doi:10.1016/j.metabol.2011.05.006
   PubMedGoogle Scholar
• Malakou E, Linardakis M, Armstrong MEG, et al. The combined effect of promoting the mediterranean diet and physical activity on metabolic risk factors in adults: a systematic review and meta-analysis of randomised controlled trials. Nutrients. 2018;10(11):E1577. doi:10.3390/nu10111577
   PubMed Web of Science ®Google Scholar
• Dvorakova-Lorenzova A, Suchanek P, Havel PJ, et al. The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism. 2006;55(3):359–365. doi:10.1016/j.metabol.2005.09.010
   PubMed Web of Science ®Google Scholar
• Merlotti C, Ceriani V, Morabito A, Pontiroli AE. Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis. Int J Obes (Lond). 2017;41(5):672–682. doi:10.1038/ijo.2017.31
   PubMedGoogle Scholar
• Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44(1):82–92. doi:10.3109/07853890.2010.526138
   PubMed Web of Science ®Google Scholar
• Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring). 2006;14(2):336–341. doi:10.1038/oby.2006.43
   PubMed Web of Science ®Google Scholar
• Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr. 2004;79(1):31–39. doi:10.1093/ajcn/79.1.31
   PubMed Web of Science ®Google Scholar
• Jung RT. Obesity as a disease. Br Med Bull. 1997;53(2):307–321. doi:10.1093/oxfordjournals.bmb.a011615
   PubMedGoogle Scholar
• Wadden TA, Anderson DA, Foster GD. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res. 1999;7(2):170–178. doi:10.1002/j.1550-8528.1999.tb00699.x
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Lee IT, Lee WJ, Tsai IC, et al. Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. Clin Chim Acta. 2012;413(9–10):944–948. doi:10.1016/j.cca.2012.02.013
   PubMedGoogle Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Tong J, Boyko EJ, Utzschneider KM, et al. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia. 2007;50(6):1156–1160. doi:10.1007/s00125-007-0651-y
   PubMedGoogle Scholar
• Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging. 2014;7(12):1221–1235. doi:10.1016/j.jcmg.2014.07.017
   PubMed Web of Science ®Google Scholar
• Park HS, Lee K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med. 2005;22(3):266–272. doi:10.1111/dme.2005.22.issue-3
   PubMedGoogle Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697–738. doi:10.1210/edrv.21.6.0415
   PubMed Web of Science ®Google Scholar
• Sam S. Differential effect of subcutaneous abdominal and visceral adipose tissue on cardiometabolic risk. Horm Mol Biol Clin Investig. 2018;33(1).
   PubMedGoogle Scholar
• Mårin P, Andersson B, Ottosson M, et al. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992;41(11):1242–1248. doi:10.1016/0026-0495(92)90016-4
   PubMedGoogle Scholar
• Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11(1):11–18. doi:10.1111/obr.2010.11.issue-1
   PubMed Web of Science ®Google Scholar
• Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–850. doi:10.1210/jcem.83.3.4660
   PubMed Web of Science ®Google Scholar
• Bruun JM, Lihn AS, Pedersen SB, Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab. 2005;90(4):2282–2289. doi:10.1210/jc.2004-1696
   PubMed Web of Science ®Google Scholar
• Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–1013. doi:10.2337/db06-1656
   PubMed Web of Science ®Google Scholar
• Pontiroli AE, Frige F, Paganelli M, Folli F. In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery. Obes Surg. 2009;19(6):745–750. doi:10.1007/s11695-008-9626-4
   PubMedGoogle Scholar
• Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319–326. doi:10.1016/j.numecd.2006.07.005
   PubMed Web of Science ®Google Scholar
• Chae JS, Paik JK, Kang R, et al. Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification. Nutr Res. 2013;33(3):195–203. doi:10.1016/j.nutres.2013.01.005
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
   PubMed Web of Science ®Google Scholar
• DeBoer MD, Filipp SL, Gurka MJ. Use of a metabolic syndrome severity Z score to track risk during treatment of prediabetes: an analysis of the diabetes prevention program. Diabetes Care. 2018;41(11):2421–2430. doi:10.2337/dc18-1079
   PubMed Web of Science ®Google Scholar
• de Mutsert R, Gast K, Widya R, et al. Associations of abdominal subcutaneous and visceral fat with insulin resistance and secretion differ between men and women: the Netherlands Epidemiology of Obesity Study. Metab Syndr Relat Disord. 2018;16(1):54–63. doi:10.1089/met.2017.0128
   PubMed Web of Science ®Google Scholar
• Ng TW, Watts GF, Barrett PH, Rye KA, Chan DC. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care. 2007;30(11):2945–2950. doi:10.2337/dc07-0768
   PubMedGoogle Scholar
• Ng TW, Chan DC, Barrett PH, Watts GF. Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome. Clin Sci (Lond). 2009;118(1):79–85. doi:10.1042/CS20090110
   PubMedGoogle Scholar
• Park HS, Sim SJ, Park JY. Effect of weight reduction on metabolic syndrome in Korean obese patients. J Korean Med Sci. 2004;19(2):202–208. doi:10.3346/jkms.2004.19.2.202
   PubMedGoogle Scholar
• Devers MC, Campbell S, Simmons D. Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease. BMJ Open Diabetes Res Care. 2016;4(1):e000195. doi:10.1136/bmjdrc-2016-000195
   PubMed Web of Science ®Google Scholar
• Wang WS, Wahlqvist ML, Hsu CC, Chang HY, Chang WC, Chen CC. Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health. 2012;12:111. doi:10.1186/1471-2458-12-111
   PubMedGoogle Scholar